Artificial Intelligence and Machine Learning- Driven Pharmaceutical Industry

Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the pharmaceutical sector at every stage—drug discovery, development, regulatory affairs, quality control, and post-marketing surveillance. These technologies improve data processing, accuracy, and timelines by using complex algorithms and large volumes of healthcare data. AI helps in drug target identification, drug design, prediction of toxicity, and pharmacokinetics modeling, as well as improving regulatory processes and pharmacovigilance. Though they have their benefits, there are still challenges such as data privacy, algorithmic bias, explainability, and accountability. Regulatory structures and ethical implications need to keep pace so that AI can be used safely and fairly in pharmaceuticals. This article discusses the existing applications, advantages, risks, and future possibilities of AI and ML in transforming drug development and healthcare outcomes.